Celldex Therapeutics, Inc. Chart

Looking at the chart above, CLDX's low point in its 52 week range is $6.90 per share, with $38.84 as the 52 week high point — that compares with a last trade of $27.42.

According to the ETF Finder at ETF Channel, CLDX makes up 1.51% of the SPDR S&P Biotech ETF ( XBI) which is trading lower by about 1% on the day Wednesday.

If you liked this article you might like

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

Celldex Therapeutics (CLDX) Stock Up on Q2 Results

Celldex Therapeutics (CLDX) Is Strong On High Volume Today